ROCKET LAB CORP (RKLB) Fundamental Analysis & Valuation

NASDAQ:RKLB • US7731211089

Current stock price

67.23 USD
-4.7 (-6.53%)
At close:
68.23 USD
+1 (+1.49%)
After Hours:

This RKLB fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

1

1. RKLB Profitability Analysis

1.1 Basic Checks

  • RKLB had negative earnings in the past year.
  • In the past year RKLB has reported a negative cash flow from operations.
  • In the past 5 years RKLB always reported negative net income.
  • RKLB had a negative operating cash flow in each of the past 5 years.
RKLB Yearly Net Income VS EBIT VS OCF VS FCFRKLB Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 -100M -200M -300M

1.2 Ratios

  • RKLB has a worse Return On Assets (-8.53%) than 69.23% of its industry peers.
  • Looking at the Return On Equity, with a value of -11.51%, RKLB is doing worse than 66.67% of the companies in the same industry.
Industry RankSector Rank
ROA -8.53%
ROE -11.51%
ROIC N/A
ROA(3y)-14.66%
ROA(5y)-13.94%
ROE(3y)-31.39%
ROE(5y)-26.23%
ROIC(3y)N/A
ROIC(5y)N/A
RKLB Yearly ROA, ROE, ROICRKLB Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 -10 -20 -30 -40 -50

1.3 Margins

  • RKLB's Gross Margin of 34.43% is fine compared to the rest of the industry. RKLB outperforms 73.08% of its industry peers.
  • In the last couple of years the Gross Margin of RKLB has grown nicely.
  • The Profit Margin and Operating Margin are not available for RKLB so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 34.43%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y56.37%
GM growth 5YN/A
RKLB Yearly Profit, Operating, Gross MarginsRKLB Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 0 -50 -100 -150

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

6

2. RKLB Health Analysis

2.1 Basic Checks

  • RKLB does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for RKLB has been increased compared to 1 year ago.
  • Compared to 5 years ago, RKLB has more shares outstanding
  • The debt/assets ratio for RKLB has been reduced compared to a year ago.
RKLB Yearly Shares OutstandingRKLB Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M
RKLB Yearly Total Debt VS Total AssetsRKLB Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

2.2 Solvency

  • RKLB has an Altman-Z score of 40.50. This indicates that RKLB is financially healthy and has little risk of bankruptcy at the moment.
  • RKLB has a Altman-Z score of 40.50. This is amongst the best in the industry. RKLB outperforms 98.72% of its industry peers.
  • RKLB has a Debt/Equity ratio of 0.10. This is a healthy value indicating a solid balance between debt and equity.
  • Looking at the Debt to Equity ratio, with a value of 0.10, RKLB belongs to the top of the industry, outperforming 82.05% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Altman-Z 40.5
ROIC/WACCN/A
WACC9.9%
RKLB Yearly LT Debt VS Equity VS FCFRKLB Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 4.08 indicates that RKLB has no problem at all paying its short term obligations.
  • RKLB has a Current ratio of 4.08. This is in the better half of the industry: RKLB outperforms 73.08% of its industry peers.
  • A Quick Ratio of 3.61 indicates that RKLB has no problem at all paying its short term obligations.
  • RKLB has a Quick ratio of 3.61. This is amongst the best in the industry. RKLB outperforms 83.33% of its industry peers.
Industry RankSector Rank
Current Ratio 4.08
Quick Ratio 3.61
RKLB Yearly Current Assets VS Current LiabilitesRKLB Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

7

3. RKLB Growth Analysis

3.1 Past

  • RKLB shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by 0.00%.
  • Looking at the last year, RKLB shows a very strong growth in Revenue. The Revenue has grown by 37.96%.
  • RKLB shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 76.43% yearly.
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10%
Revenue 1Y (TTM)37.96%
Revenue growth 3Y41.82%
Revenue growth 5Y76.43%
Sales Q2Q%35.7%

3.2 Future

  • The Earnings Per Share is expected to grow by 39.89% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 33.30% on average over the next years. This is a very strong growth
EPS Next Y42.89%
EPS Next 2Y49.01%
EPS Next 3Y39.89%
EPS Next 5YN/A
Revenue Next Year47.81%
Revenue Next 2Y43.53%
Revenue Next 3Y35.77%
Revenue Next 5Y33.3%

3.3 Evolution

  • The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
RKLB Yearly Revenue VS EstimatesRKLB Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 2B 4B 6B
RKLB Yearly EPS VS EstimatesRKLB Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 2028 0 0.2 -0.2 -0.4

More info and screens

Find the best growth stocksShow best growing peers

1

4. RKLB Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for RKLB. In the last year negative earnings were reported.
  • Also next year RKLB is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RKLB Price Earnings VS Forward Price EarningsRKLB Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 -100 -200 -300

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
RKLB Per share dataRKLB EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

  • RKLB's earnings are expected to grow with 39.89% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y49.01%
EPS Next 3Y39.89%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. RKLB Dividend Analysis

5.1 Amount

  • RKLB does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

RKLB Fundamentals: All Metrics, Ratios and Statistics

ROCKET LAB CORP

NASDAQ:RKLB (3/20/2026, 8:20:57 PM)

After market: 68.23 +1 (+1.49%)

67.23

-4.7 (-6.53%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryAerospace & Defense
Earnings (Last)02-26
Earnings (Next)N/A
Inst Owners56.2%
Inst Owner Change1.23%
Ins Owners0.55%
Ins Owner Change-8.9%
Market Cap38.15B
Revenue(TTM)601.80M
Net Income(TTM)-198.21M
Analysts80
Price Target85.59 (27.31%)
Short Float %3.5%
Short Ratio0.92
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)38.16%
Min EPS beat(2)4.51%
Max EPS beat(2)71.81%
EPS beat(4)3
Avg EPS beat(4)18.26%
Min EPS beat(4)-11.38%
Max EPS beat(4)71.81%
EPS beat(8)7
Avg EPS beat(8)16.09%
EPS beat(12)9
Avg EPS beat(12)10.89%
EPS beat(16)11
Avg EPS beat(16)9.02%
Revenue beat(2)1
Avg Revenue beat(2)-0.56%
Min Revenue beat(2)-1.31%
Max Revenue beat(2)0.19%
Revenue beat(4)2
Avg Revenue beat(4)0.63%
Min Revenue beat(4)-1.31%
Max Revenue beat(4)4.63%
Revenue beat(8)3
Avg Revenue beat(8)-0.39%
Revenue beat(12)4
Avg Revenue beat(12)-0.93%
Revenue beat(16)7
Avg Revenue beat(16)0.16%
PT rev (1m)0%
PT rev (3m)30.3%
EPS NQ rev (1m)5.61%
EPS NQ rev (3m)17.62%
EPS NY rev (1m)2.71%
EPS NY rev (3m)14.59%
Revenue NQ rev (1m)3.15%
Revenue NQ rev (3m)6.05%
Revenue NY rev (1m)-1.34%
Revenue NY rev (3m)-0.41%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 63.39
P/FCF N/A
P/OCF N/A
P/B 22.16
P/tB 29.54
EV/EBITDA N/A
EPS(TTM)-0.37
EYN/A
EPS(NY)-0.21
Fwd EYN/A
FCF(TTM)-0.57
FCFYN/A
OCF(TTM)-0.29
OCFYN/A
SpS1.06
BVpS3.03
TBVpS2.28
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -8.53%
ROE -11.51%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 34.43%
FCFM N/A
ROA(3y)-14.66%
ROA(5y)-13.94%
ROE(3y)-31.39%
ROE(5y)-26.23%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y56.37%
GM growth 5YN/A
F-Score5
Asset Turnover0.26
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 355.72%
Cap/Sales 25.97%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 4.08
Quick Ratio 3.61
Altman-Z 40.5
F-Score5
WACC9.9%
ROIC/WACCN/A
Cap/Depr(3y)246.33%
Cap/Depr(5y)223.49%
Cap/Sales(3y)21.24%
Cap/Sales(5y)25.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%10%
EPS Next Y42.89%
EPS Next 2Y49.01%
EPS Next 3Y39.89%
EPS Next 5YN/A
Revenue 1Y (TTM)37.96%
Revenue growth 3Y41.82%
Revenue growth 5Y76.43%
Sales Q2Q%35.7%
Revenue Next Year47.81%
Revenue Next 2Y43.53%
Revenue Next 3Y35.77%
Revenue Next 5Y33.3%
EBIT growth 1Y-20.57%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year95.77%
EBIT Next 3Y50.21%
EBIT Next 5Y40.47%
FCF growth 1Y-177.46%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-238.56%
OCF growth 3YN/A
OCF growth 5YN/A

ROCKET LAB CORP / RKLB Fundamental Analysis FAQ

Can you provide the ChartMill fundamental rating for ROCKET LAB CORP?

ChartMill assigns a fundamental rating of 4 / 10 to RKLB.


What is the valuation status for RKLB stock?

ChartMill assigns a valuation rating of 1 / 10 to ROCKET LAB CORP (RKLB). This can be considered as Overvalued.


How profitable is ROCKET LAB CORP (RKLB) stock?

ROCKET LAB CORP (RKLB) has a profitability rating of 1 / 10.


Can you provide the financial health for RKLB stock?

The financial health rating of ROCKET LAB CORP (RKLB) is 6 / 10.